1. Home
  2. CGEM vs GAU Comparison

CGEM vs GAU Comparison

Compare CGEM & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$11.84

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Logo Galiano Gold Inc.

GAU

Galiano Gold Inc.

HOLD

Current Price

$3.15

Market Cap

670.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGEM
GAU
Founded
2016
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
670.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CGEM
GAU
Price
$11.84
$3.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
2
Target Price
$28.13
$3.00
AVG Volume (30 Days)
707.4K
2.9M
Earning Date
02-26-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$352,642,000.00
Revenue This Year
N/A
$82.50
Revenue Next Year
N/A
$57.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
111.43
52 Week Low
$5.68
$1.00
52 Week High
$13.33
$3.26

Technical Indicators

Market Signals
Indicator
CGEM
GAU
Relative Strength Index (RSI) 57.77 67.39
Support Level $11.53 $3.01
Resistance Level $12.99 $3.26
Average True Range (ATR) 0.76 0.15
MACD 0.12 0.02
Stochastic Oscillator 61.36 83.33

Price Performance

Historical Comparison
CGEM
GAU

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About GAU Galiano Gold Inc.

Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.

Share on Social Networks: